Journal of Viral Hepatitis 2012 VOL. 19 NO. 2

分享 (0)

REVIEW ARTICLE

红细胞生成素对聚乙二醇干扰素+利巴韦林治疗HCV感染之持续病毒应答的影响：系统回顾与荟萃分析

Impact of erythropoietin on sustained virological response to peginterferon and ribavirin therapy for HCV infection: a systematic review and meta‐analysis

慢性丙肝治疗期间贫血处理中使用红细胞生成素的批评性评论

Critical review of the use of erythropoietin in the treatment of anaemia during therapy for chronic hepatitis C

ORIGINAL ARTICLES

无快速病毒应答的感染HCV基因1型患者在聚乙二醇干扰素加利巴韦林标准治疗之后其特征可以复发

Characterization of nonrapid virologic response patients infected with HCV genotype 1 who may relapse after standard therapy with peginterferon plus ribavirin

肝铁超负荷在慢性乙型肝炎中常见，而在丁型肝炎病毒双重感染的患者中更为严重

Hepatic iron overload is common in chronic hepatitis B and is more severe in patients coinfected with hepatitis D virus

在不同组慢性乙肝患者中，血清microRNA-122水平

Serum microRNA‐122 levels in different groups of patients with chronic hepatitis B virus infection

自发性HBeAg血清转换之后转氨酶持续正常10年以上患者系列HBV DNA水平

Serial HBV DNA levels in patients with persistently normal transaminase over 10 years following spontaneous HBeAg seroconversion

丙型肝炎在干扰素维持下纤维化进展用血检比肝脏形态计量更好

Fibrosis progression under maintenance interferon in hepatitis C is better detected by blood test than liver morphometry

在慢性感染患者中，乙肝病毒核心、表面及聚合酶基因置换率比较

Comparison of the hepatitis B virus core, surface and polymerase gene substitution rates in chronically infected patients

用于肝纤维化分期的听辐射力刺激成像表现：集合的荟萃分析

Performance of Acoustic Radiation Force Impulse imaging for the staging of liver fibrosis: a pooled meta‐analysis

长期随访慢性丙肝持续病毒应答患者的实验室数据纵向变化

Longitudinal changes of the laboratory data of chronic hepatitis C patients with sustained virological response on long‐term follow‐up

静脉用药：在HCV感染中，不是达到持续病毒应答的障碍

Intravenous drug use: not a barrier to achieving a sustained virological response in HCV infection

瞬时弹性成像预测慢性肝病患者的临床结果

Transient elastography for predicting clinical outcomes in patients with chronic liver disease

IκB激酶被沙立度胺抑制增加丙肝病毒RNA复制

Inhibition of IκB kinase by thalidomide increases hepatitis C virus RNA replication

聚乙二醇干扰素α-2b+基于体重的利巴韦林治疗达到快速病毒应答的慢性丙肝基因1型低病毒载量患者24周

Peginterferon alfa‐2b plus weight‐based ribavirin for 24 weeks in patients with chronic hepatitis C virus genotype 1 with low viral load who achieve rapid viral response

在欧洲人群中，肿瘤坏死因子-α-238A等位基因增加慢性HBV感染风险

The tumour necrosis factor‐α‐238A allele increases the risk of chronic HBV infection in European populations

在初级保健诊所检测丙肝病毒试验

Examining hepatitis c virus testing practices in primary care clinics

乙肝病毒感染对代谢和修饰因素的影响

Impact of hepatitis B virus infection on metabolic profiles and modifying factors

CCL5 mRNA是慢性丙肝早期纤维化的标志，并经干扰素α治疗和toll-样受体3信号调节

CCL5 mRNA is a marker for early fibrosis in chronic hepatitis C and is regulated by interferon‐α therapy and toll‐like receptor 3 signalling

特拉瑞韦，一种新的蛋白酶抑制剂用于难治性慢性丙肝基因1型患者的安全性和有效性

Efficacy and safety of telaprevir, a new protease inhibitor, for difficult‐to‐treat patients with genotype 1 chronic hepatitis C

乙肝病毒抑制自然杀伤细胞与类浆细胞树枝状细胞之间功能的相互影响

Hepatitis B virus suppresses the functional interaction between natural killer cells and plasmacytoid dendritic cells

HIV病毒载量与肝损伤间接指标的联系

The association of HIV viral load with indirect markers of liver injury

丙肝患者脑小神经胶质活化：体内神经炎证据

Cerebral microglial activation in patients with hepatitis c: in vivo evidence of neuroinflammation

在有或无既往暴露于乙肝病毒的患者中，抗病毒治疗的持续病毒应答之后丙肝病毒持续感染

Hepatitis C virus persistence after sustained virological response to antiviral therapy in patients with or without past exposure to hepatitis B virus

诊断戊型肝炎病毒感染的免疫组织化学

Immunohistochemistry for the diagnosis of hepatitis E virus infection

在亚洲人群中，肿瘤坏死因子-α-857T等位基因减少乙肝病毒感染风险

Tumour necrosis factor‐α‐857T allele reduces the risk of hepatitis B virus infection in an Asian population

特拉瑞韦单独治疗丙肝病毒基因型1b感染者12周的安全性、药代动力学及耐药变种

Safety, pharmacokinetics and resistant variants of telaprevir alone for 12 weeks in hepatitis C virus genotype 1b infection

在慢性HBV感染的患者中，肝内干扰素信号激活前与干扰素α治疗无应答相关

Preactivation of the interferon signalling in liver is correlated with nonresponse to interferon alpha therapy in patients chronically infected with hepatitis B virus

中国移民中的特征性乙肝斑点

Characterizing hepatitis B stigma in Chinese immigrants

在离体肝脏切片试验中， MxA和OAS1的肝脏表达独立预测慢性丙肝治疗结果

Hepatic expression of MxA and OAS1 in an ex vivo liver slice assay independently predicts treatment outcomes in chronic hepatitis C

治疗前HBeAg水平与HBeAg水平早期下降预测恩替卡韦治疗HBeAg阳性慢性乙肝的病毒应答

Pretreatment HBeAg level and an early decrease in HBeAg level predict virologic response to entecavir treatment for HBeAg‐positive chronic hepatitis B

白种人、西班牙人、亚裔美国病人感染丙肝病毒风险因素的前瞻性研究

Prospective study of risk factors for hepatitis C virus acquisition by Caucasian, Hispanic, and Asian American patients

不论有或无聚乙二醇干扰素α-2b，伯塞瑞韦连续治疗期间丙肝病毒NS3蛋白酶区域选择性变异

Mutations selected in the hepatitis C virus NS3 protease domain during sequential treatment with boceprevir with and without pegylated interferon alfa‐2b

抑制NS3蛋白酶活性介导黄酮类橡黄素抑制丙肝病毒

Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity

血清PAI-1是聚乙二醇干扰素-α-2b加利巴韦林治疗慢性丙肝病毒感染应答的新奇预测指标

Serum PAI‐1 is a novel predictor for response to pegylated interferon‐α‐2b plus ribavirin therapy in chronic hepatitis C virus infection

在HBsAg阳性母亲所生婴儿中，被动--主动免疫预防失败相关的病毒因素

Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg‐positive mothers

急性病毒性肝炎和凝血病儿童临床结果的预测指标

Predictors of outcome in children with acute viral hepatitis and coagulopathy